Envista vs Dentsply Sirona
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Envista and Dentsply Sirona side by side, using each one’s latest annual report. Here is what stands out:
- Dentsply Sirona is the larger business, with $3.7B of revenue in fiscal 2025 against $2.7B for Envista.
- Envista grew revenue faster (8.3%, against −3.0%).
- Envista kept more of each dollar of sales as operating profit (8.0% operating margin, against −11.5%).
- Envista turned more of its sales into free cash flow (8.5% FCF margin, against 2.8%).
- Envista earned a higher return on the capital invested in it (3.2%, against −9.9%).
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
Envista
NVST
9/10
Revenue growth5-year growthGross marginOperating marginNet marginFCF marginReturn on capitalReturn on equityPiotroski F-score
Dentsply Sirona
XRAY
1/10
Share count change
Side by side
Best in the row
| Latest fiscal year | NVST FY25 | XRAY FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.9B | $1.8B |
| Revenue | $2.7B | $3.7B |
| Free cash flow | $230M | $104M |
| Net income | $47.0M | −$598M |
| Growth | ||
| Revenue growth | 8.3% | −3.0% |
| 5-year growth | 7.1% | 2.0% |
| Share count change | −1.7% | −1.9% |
| Profitability | ||
| Gross margin | 54.7% | 50.0% |
| Operating margin | 8.0% | −11.5% |
| Net margin | 1.7% | −16.3% |
| FCF margin | 8.5% | 2.8% |
| Return on capital | 3.2% | −9.9% |
| Return on equity | 1.6% | −36.5% |
| Balance sheet | ||
| Net debt | $237M | $2.0B |
| Net debt / EBITDA | 0.7x | — |
| Dividends and buybacks | $167M | $128M |
| Valuation & quality | ||
| P/E | 40.8x | — |
| Piotroski F-score | 7 | 6 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.